Grown Rogue International (GRUSF) Non-Current Deferred Tax Liability (2024)
Grown Rogue International (GRUSF) recorded quarterly Non-Current Deferred Tax Liability of $58181.0 in Q4 2024.
Grown Rogue International (GRUSF) Non-Current Deferred Tax Liability (2024) Analysis & Trends
Grown Rogue International's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $58181.0 for Q4 2024.
- In Q4 2024, Non-Current Deferred Tax Liability changed N/A year-over-year to $58181.0; the TTM figure through Dec 2024 stood at $58181.0 (changed N/A YoY), while the FY2024 annual figure was $58181.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability was $58181.0 for Q4 2024 at Grown Rogue International.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $58181.0 in Q4 2024 to a low of $58181.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 58,181.00 |
| Dec 31, 2024 | 58,181.00 |